Pathogenesis and therapy of amyotrophic lateral sclerosis /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Conference Proceeding Book |
| Language: | English |
| Published: |
Philadelphia :
Lippincott-Raven,
[1995]
|
| Series: | Advances in neurology.
v. 68. |
| Subjects: |
Table of Contents:
- Overview of the pathogenesis and therapy of amyotrophic lateral sclerosis
- Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis
- Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis : a discussion
- The possible role of a secondary pathogenetic factor in amyotrophic lateral sclerosis
- Copper/zinc superoxide dismutase mutations and free radical damage in amyotrophic lateral sclerosis
- Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis
- Amyotrophic lateral sclerosis : an autoimmune disease
- Anti-calcium channel autoantibodies in amyotrophic lateral sclerosis : a review of the evidence
- Animal models of amyotrophic lateral sclerosis
- Animal models of amyotrophic lateral sclerosis : a discussion
- Amyotrophic lateral sclerosis with paraproteins and autoantibodies
- Amyotrophic lateral sclerosis with paraproteins and autoantibodies : a discussion
- Chronic motor neuropathies
- Amyotrophic lateral sclerosis : a multifactorial disease
- The viral hypothesis
- Neuropathology of the cortex in amyotrophic lateral sclerosis with dementia
- The diagnosis of amyotrophic lateral sclerosis
- Atypical amyotrophic lateral sclerosis
- The diagnosis of amyotrophic lateral sclerosis : a discussion
- Clues to the diagnosis of amyotrophic lateral sclerosis
- Natural history of amyotrophic lateral sclerosis : quantification of symptoms, signs, strength and function
- Natural history of amyotrophic lateral sclerosis : observations with the charing cross amyotrophic lateral sclerosis rating scales
- Nautral history of amyotrophic lateral sclerosis : a discussion
- Issues in amyotrophic lateral sclerosis clinical trial design
- Megaslope, natural course and historical controls in amyotrophic lateral sclerosis trials
- The design of clinical trials in amyotrophic lateral sclerosis
- Use of growth factors in the treatment of motor neuron diseases
- Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis : potential and pitfalls
- Neurotrophic factors and amyotrophic lateral sclerosis
- Excitotoxic blocking strategies in amyotrophic lateral sclerosis
- Excitotoxic blocking strategies in amyotrophic lateral sclerosis : a discussion
- Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonists be used in amyotrophic lateral sclerosis
- The biopharmaceutical industry and new drugs for amyotrophic lateral sclerosis
- The biopharmaceutical industry and new drugs for amyotrophic lateral sclerosis : a discussion